Migration Kinetics and Final Destination of Type 1 and Type 2 CD8 Effector Cells Predict Protection Against Pulmonary Virus Infection

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1999 Jan 20

PMID 9892624

Citations 70

Authors

A Cerwenka

T M Morgan

A G Harmsen

R W Dutton

Affiliations

Soon will be listed here.

Abstract

The requirements for CD8 T cells to provide protection against a localized virus infection in models of adoptive immunotherapy are not well defined. Here we investigated the protective value of defined in vitro-generated hemagglutinin (HA) peptide-specific primary CD8 T cell effectors from the clone 4 T cell receptor transgenic mice, secreting type 1 or type 2 cytokines, against pulmonary infection with whole influenza virus. Cytotoxic T lymphocytes producing type 1 and type 2 cytokine (Tc1 and Tc2) populations were equally cytolytic, but Tc1 effectors and not Tc2 effectors reduced the pulmonary virus titer early during infection. Host recovery mediated by Tc1 effectors was found to be independent of interferon gamma production. Tc2 effectors entered the lung with delayed kinetics as compared with Tc1 effectors, and after lung entry Tc2 effector cells did not localize near the infected airway epithelium as did Tc1 effectors but were found within clusters of inflammatory cells distant from the epithelium. We also show that the expression of several chemokine receptors was selectively regulated in the Tc1 and Tc2 subsets. Thus, the protective value of a CD8 cell population against pulmonary influenza virus infection is strongly correlated with its ability to exert its effector potential at the site of virus infection.

Citing Articles

Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development.

Pandey A, Madan R, Singh S Curr Microbiol. 2022; 79(10):306.

PMID: 36064873 PMC: 9444117. DOI: 10.1007/s00284-022-03003-3.

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza.

Williams C, Roy S, Sun W, Furuya A, Wijesundara D, Furuya Y Clin Transl Immunology. 2022; 11(3):e1381.

PMID: 35356066 PMC: 8958247. DOI: 10.1002/cti2.1381.

Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.

Calzas C, Mao M, Turpaud M, Viboud Q, Mettier J, Figueroa T Front Immunol. 2021; 12:772550.

PMID: 34868036 PMC: 8632632. DOI: 10.3389/fimmu.2021.772550.

Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.

Paillet J, Plantureux C, Levesque S, Naour J, Stoll G, Sauvat A J Exp Med. 2021; 218(10).

PMID: 34495298 PMC: 8429038. DOI: 10.1084/jem.20200853.

Antigenic sites in SARS-CoV-2 spike RBD show molecular similarity with pathogenic antigenic determinants and harbors peptides for vaccine development.

Dakal T Immunobiology. 2021; 226(5):152091.

PMID: 34303920 PMC: 8297981. DOI: 10.1016/j.imbio.2021.152091.

References

Salgame P, Abrams J, Clayberger C, Goldstein H, Convit J, Modlin R . Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991; 254(5029):279-82. DOI: 10.1126/science.254.5029.279. View

Taguchi T, McGhee J, Coffman R, Beagley K, Eldridge J, Takatsu K . Analysis of Th1 and Th2 cells in murine gut-associated tissues. Frequencies of CD4+ and CD8+ T cells that secrete IFN-gamma and IL-5. J Immunol. 1990; 145(1):68-77. View

Yap K, Ada G, McKenzie I . Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature. 1978; 273(5659):238-9. DOI: 10.1038/273238a0. View

Fellous M, Nir U, Wallach D, Merlin G, Rubinstein M, Revel M . Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci U S A. 1982; 79(10):3082-6. PMC: 346357. DOI: 10.1073/pnas.79.10.3082. View

Lukacher A, Braciale V, Braciale T . In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med. 1984; 160(3):814-26. PMC: 2187390. DOI: 10.1084/jem.160.3.814. View

Croft M, Carter L, Swain S, Dutton R . Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med. 1994; 180(5):1715-28. PMC: 2191720. DOI: 10.1084/jem.180.5.1715. View

Carter L, Dutton R . Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J Immunol. 1995; 155(3):1028-31. View

Sad S, Marcotte R, Mosmann T . Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity. 1995; 2(3):271-9. DOI: 10.1016/1074-7613(95)90051-9. View

Coyle A, Erard F, Bertrand C, Walti S, Pircher H, Le Gros G . Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med. 1995; 181(3):1229-33. PMC: 2191899. DOI: 10.1084/jem.181.3.1229. View

10.

Graham M, Braciale V, Braciale T . Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med. 1994; 180(4):1273-82. PMC: 2191682. DOI: 10.1084/jem.180.4.1273. View

11.

Baumgarth N, Brown L, Jackson D, Kelso A . Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J Virol. 1994; 68(11):7575-81. PMC: 237205. DOI: 10.1128/JVI.68.11.7575-7581.1994. View

12.

Maggi E, Giudizi M, Biagiotti R, Annunziato F, Manetti R, Piccinni M . Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med. 1994; 180(2):489-95. PMC: 2191625. DOI: 10.1084/jem.180.2.489. View

13.

Sarawar S, Doherty P . Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol. 1994; 68(5):3112-9. PMC: 236801. DOI: 10.1128/JVI.68.5.3112-3119.1994. View

14.

Graham M, Dalton D, Giltinan D, Braciale V, Stewart T, Braciale T . Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med. 1993; 178(5):1725-32. PMC: 2191239. DOI: 10.1084/jem.178.5.1725. View

15.

Erard F, Wild M, Garcia-Sanz J, Le Gros G . Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. Science. 1993; 260(5115):1802-5. DOI: 10.1126/science.8511588. View

16.

Falchetti R, Lanzilli G, Casalinuovo I, Gaziano R, Palamara A, Di Francesco P . Splenic CD4+ and CD8+ T cells from influenza immune mice concurrently produce in vitro IL2, IL4, and IFN-gamma. Cell Immunol. 1996; 170(2):222-9. DOI: 10.1006/cimm.1996.0155. View

17.

Morgan D, Liblau R, Scott B, Fleck S, McDevitt H, Sarvetnick N . CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol. 1996; 157(3):978-83. View

18.

Carter L, Dutton R . Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol. 1996; 8(3):336-42. DOI: 10.1016/s0952-7915(96)80122-1. View

19.

Mosmann T, Sad S . The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996; 17(3):138-46. DOI: 10.1016/0167-5699(96)80606-2. View

20.

Meeusen E, Premier R, Brandon M . Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells?. Immunol Today. 1996; 17(9):421-4. DOI: 10.1016/0167-5699(96)10055-4. View